Literature DB >> 22752287

High sensitivity for BRCA1/2 mutations in breast/ovarian kindreds: are there still other breast/ovary genes to be discovered?

Miriam J Smith, Franchesca L Gifford, Fiona Lalloo, William G Newman, D Gareth R Evans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22752287     DOI： 10.1007/s10549-012-2130-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  2 in total

1.  Sensitivity of BRCA1/2 testing in high-risk breast/ovarian/male breast cancer families: little contribution of comprehensive RNA/NGS panel testing.

Authors:  Helen Byers; Yvonne Wallis; Elke M van Veen; Fiona Lalloo; Kim Reay; Philip Smith; Andrew J Wallace; Naomi Bowers; William G Newman; D Gareth Evans
Journal:  Eur J Hum Genet       Date:  2016-06-08       Impact factor: 4.246

2.  Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scores.

Authors:  D G Evans; E R Woodward; S J Howell; S Verhoef; A Howell; F Lalloo
Journal:  Fam Cancer       Date:  2017-04       Impact factor: 2.375
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.